| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T21 |
0-15 |
Sentence |
denotes |
1 Introduction |
| T22 |
16-139 |
Sentence |
denotes |
Several generations have been exposed to COVID-19 under different conditions of life at varying locations around the world. |
| T23 |
140-246 |
Sentence |
denotes |
As long as the COVID-19 continues to spread, its power of genome modification would probably be increased. |
| T24 |
247-501 |
Sentence |
denotes |
What concerns us more is that the 2019-nCoV, by the process of modification of genome structure, might become more and more fitted to humans to profoundly affect those who have already escaped – children and young people without a pre-existing condition. |
| T25 |
502-656 |
Sentence |
denotes |
No one can tell how much time it takes to reach a new level of perfection, and that the development of vaccines for active immunization is a long process. |
| T26 |
657-757 |
Sentence |
denotes |
Moreover, most of the best available anti-viral agents are not helpful in the treatment of COVID-19. |
| T27 |
758-1049 |
Sentence |
denotes |
A randomized controlled trial of 199 hospitalized adults with confirmed COVID-19 demonstrated no actual difference between patients who received lopinavir-ritonavir and patients who received standard care alone in clinical improvement, death rate, and positive virus test rate at day 28 [1]. |
| T28 |
1050-1195 |
Sentence |
denotes |
Here we review intermediate indicators of the pathogenesis of COVID-19 that have the potential of being considered for the treatment of COVID-19. |
